Opaleye Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-62,501	Closed	-$1.39M	–	44
2025 Q1	$1.39M	Buy	+62,501	New	+$1.29M	0.31%	38
2024 Q1	–	Sell	-37,500	Closed	-$640K	–	57
2023 Q4	$640K	Buy	+37,500	New	+$616K	0.17%	46
2022 Q3	–	Sell	-814,250	Closed	-$7.89M	–	47
2022 Q2	$7.89M	Sell	814,250 -298,250	-27%	-$2.78M	3.56%	9
2022 Q1	$11.1M	Buy	1,112,500 +87,500	+9%	+$927K	3.43%	10
2021 Q4	$12.1M	Sell	1,025,000 -285,000	-22%	-$3.5M	2.56%	12
2021 Q3	$14.9M	Buy	1,310,000 +154,800	+13%	+$2.02M	2.79%	11
2021 Q2	$16.1M	Buy	1,155,200 +834,274	+260%	+$12.7M	2.67%	11
2021 Q1	$5.94M	Buy	320,926 +96,826	+43%	+$1.98M	0.87%	34
2020 Q4	$3.96M	Sell	224,100 -113,900	-34%	-$2M	0.52%	41
2020 Q3	$8.78M	Sell	338,000 -6,500	-2%	-$122K	1.72%	25
2020 Q2	$8.78M	Buy	+344,500	New	+$7.2M	1.77%	19